Scheme 1From: Programmed ROS/CO-releasing nanomedicine for synergetic chemodynamic-gas therapy of cancerSchematic illustration of the mechanisms for acid-triggered sequential release of ROS and CO by the FeCO-MnO2@MSN nanomedicine for synergetic CDT and CDGT, which target the nucleus (N) and mitochondrion (M), respectivelyBack to article page